期刊文献+

高帧频超声造影评价肝细胞癌血管形态与风险因素的研究

Evaluation of relationsip between vascular morphology and risk factors for hepatocellular carcinoma by high-frame-rate contrast-enhanced ultrasound
原文传递
导出
摘要 目的探索高帧频超声造影(H-CEUS)检查肝细胞癌(HCC)动脉期血流灌注的不同形态特征及其与风险因素的关系。方法回顾2021年1月至2022年6月在解放军总医院第一医学中心行手术治疗的HCC患者78例,所有患者术前均行常规超声与H-CEUS检查。根据H-CEUS动脉早期灌注形成的血管形态进行分型,并采用χ^(2)检验比较不同HCC分化程度、有无微血管侵犯(MVI)和不同肿瘤大小组间血管形态的差异。结果H-CEUS显示HCC动脉期血管形态可以分为4型,其中Ⅰ型31例(39.7%),Ⅱ型1例(1.3%),Ⅲ型14例(18.0%),Ⅳ型32例(41.0%)。78例HCC患者中,高-中高分化HCC有19例(24.3%),中分化HCC有46例(59.0%),中低-低分化HCC有13例(16.7%);23例(29.5%)病灶存在MVI,55例(70.5%)无MVI;直径≤3 cm的病灶有41例(52.6%),>3 cm的病灶有37例(47.4%)。不同HCC分化程度、有无MVI、不同肿瘤大小组间血管形态分型分布差异具有统计学意义(χ^(2)=13.04、11.92、19.25,P=0.023、=0.004、<0.001),Ⅳ型血管形态在中低-低分化组(84.6%)、MVI组(65.2%)及>3 cm HCC组(62.2%)占比更高。对于≤3 cm HCC,MVI组与无MVI组间的血管形态差异也具有统计学意义(χ^(2)=9.00,P=0.015),Ⅳ型血管形态在MVI组占比(54.5%)更高。结论H-CEUS可以显示HCC动脉期的不同微血管形态,不同风险因素组间血管形态存在差异,H-CEUS可能为术前判断肿瘤分化程度及MVI风险提供可靠的影像学参考。 Objective To explore the relationship between different vascular morphological characteristics and risk factors for hepatocellular carcinoma(HCC).Methods This retrospective study enrolled 78 patients with single hepatocellular carcinoma(HCC)who underwent surgery at the First Medical Centre,Chinese PLA General Hospital from January 2021 to June 2022.All patients underwent ultrasound and high-frame-rate contrast-enhanced ultrasound scanning before surgery.According to the differences of vascular morphology on high-frame-rate contrast-enhanced ultrasound in the arterial phase,the patients were divided into different groups to compare the relationship between vascular morphology and degree of differentiation,microvascular invasion(MVI),and tumor size in each group by the Chi-square test.Results Vascular morphology of HCC in the arterial phase can be divided into four types by high-frame-rate contrast-enhanced ultrasound,including typeⅠin 31(39.7%)cases,typeⅡin 1(1.3%),typeⅢin 14(18.0%),and typeⅣin 32(41.0%).Among the 78 HCC patients included,19(24.3%)had well or well-to-moderately differentiated HCC,46(59.0%)had moderately differentiated HCC,and 13 had moderately-to-poorly or poorly differentiated HCC(16.7%);23(29.5%)had MVI and 55(70.5%)had no MVI;41(52.6%)had a lesion≤3 cm diameter and 37(47.4%)had a lesion>3 cm diameter.There were statistical differences in vascular morphology according to HCC differentiation degree,MVI,and tumor size(χ^(2)=13.04,P=0.023;χ^(2)=11.92,P=0.004;χ^(2)=19.25,P<0.001),and there was a significant higher proportion of typeⅣvascular morphology in the moderate-poor and poor differentiation group(84.6%),MVI group(65.2%),and>3 cm diameter group(62.2%).For HCC with a diameter≤3 cm,there was a statistical difference between the MVI group and the non-MVI group in vascular morphology(χ^(2)=9.00,P=0.015),and typeⅣvascular morphology had a higher percentage in the MVI group(54.5%).Conclusion High-frame-rate contrast-enhanced ultrasound can display different vascular morphologies of HCC in the arterial phase,and there are differences in vascular morphology among different risk factor groups.High-frame-rate contrast-enhanced ultrasound may be a feasible imaging technique to determine the degree of tumor differentiation and MVI risk before surgery.
作者 李淼 朱连华 韩鹏 姜波 费翔 Li Miao;Zhu Lianhua;Han Peng;Jiang Bo;Fei Xiang(Department of Ultrasound,the First Medical Centre,Chinese PLA General Hospital,Beijing 100853,China)
出处 《中华医学超声杂志(电子版)》 CSCD 北大核心 2023年第9期911-915,共5页 Chinese Journal of Medical Ultrasound(Electronic Edition)
关键词 肝细胞癌 超声造影 高帧频 微血管侵犯 Hepatocellular carcinoma Contrast-enhanced ultrasound,high-frame-rate Microvascular invasion
  • 相关文献

参考文献4

二级参考文献14

  • 1K. V. Menon,A. R. Hakeem,N. D. Heaton.Meta‐analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma[J]. Aliment Pharmacol Ther . 2012 (4)
  • 2Luigi Bolondi,Andrew Burroughs,Jean-Fran?ois Dufour,Peter Galle,Vincenzo Mazzaferro,Fabio Piscaglia,Jean Raoul,Bruno Sangro.Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions[J].Semin Liver Dis.2012(04)
  • 3Alessandro Cucchetti,Fabio Piscaglia,Matteo Cescon,Antonio Colecchia,Giorgio Ercolani,Luigi Bolondi,Antonio D. Pinna.Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma&lt;!-- Doctopic: CAN --&gt;[J].Journal of Hepatology.2013(2)
  • 4Jean–Charles Nault,Aurélien De Reyniès,Augusto Villanueva,Julien Calderaro,Sandra Rebouissou,Gabrielle Couchy,Thomas Decaens,Dominique Franco,Sandrine Imbeaud,Francis Rousseau,Daniel Azoulay,Jean Saric,Jean–Frédéric Blanc,Charles Balabaud,Paulette Bioulac–Sage,Alexis Laurent,Pierre Laurent–Puig,Josep M. Llovet,Jessica Zucman–Rossi.A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection[J].Gastroenterology.2013(1)
  • 5Guido Torzilli,Jacques Belghiti,Norihiro Kokudo,Tadatoshi Takayama,Lorenzo Capussotti,Gennaro Nuzzo,Jean-Nicolas Vauthey,Michael A. Choti,Eduardo De Santibanes,Matteo Donadon,Emanuela Morenghi,Masatoshi Makuuchi.A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations?: An Observational Study of the HCC East-West Study Group[J].Annals of Surgery.2013(5)
  • 6Joon Suk Kim,Won Kim,Young Ho So,Su Jong Yu,Byeong Gwan Kim.Topographical Impact of Hepatitis B-related Hepatocellular Carcinoma on Local Recurrence After Radiofrequency Ablation[J].Journal of Clinical Gastroenterology.2014(1)
  • 7Young-Joo Jin,Young-Hwa Chung,Jeong A. Kim,Wonhyeong Park,Don Lee,Ju Hyun Shim,Danbi Lee,Kang Mo Kim,Young-Suk Lim,Han Chu Lee,Yung Sang Lee,Pyo Nyun Kim,Kyu Bo Sung.Predisposing Factors of Hepatocellular Carcinoma Recurrence Following Complete Remission in Response to Transarterial Chemoembolization[J].Digestive Diseases and Sciences.2013(6)
  • 8Jeff Siu-Wang Wong,Grace Lai-Hung Wong,Anthony Wing-Hung Chan,Vincent Wai-Sun Wong,Yue-Sun Cheung,Ching-Ning Chong,John Wong,Kit-Fai Lee,Henry Lik-Yuen Chan,Paul Bo-San Lai.Liver Stiffness Measurement by Transient Elastography as a Predictor on Posthepatectomy Outcomes[J].Annals of Surgery.2013(5)
  • 9Yujin Hoshida,Augusto Villanueva,Angelo Sangiovanni,Manel Sole,Chin Hur,Karin L. Andersson,Raymond T. Chung,Joshua Gould,Kensuke Kojima,Supriya Gupta,Bradley Taylor,Andrew Crenshaw,Stacey Gabriel,Beatriz Minguez,Massimo Iavarone,Scott L. Friedman,Massimo Colombo,Josep M. Llovet,Todd R. Golub.Prognostic Gene Expression Signature for Patients With Hepatitis C–Related Early-Stage Cirrhosis[J].Gastroenterology.2013(5)
  • 10Manuel Rodríguez-Perálvarez,Tu Vinh Luong,Lorenzo Andreana,Tim Meyer,Amar Paul Dhillon,Andrew Kenneth Burroughs.A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic Variability[J].Annals of Surgical Oncology.2013(1)

共引文献191

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部